Medical Equipment

Global Stereotactic Surgery Devices Industry Trends: Where the Market Is Headed by 2029

November 18, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Stereotactic Surgery Devices Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The market for stereotactic surgery apparatus has experienced consistent expansion across recent years, and projections indicate continued upward movement, with the value expected to rise from 21.8 billion USD in 2024 to 22.44 billion USD in 2025, marking a compound annual growth rate (CAGR) of 2.9%; this expansion throughout the historical timeframe stems from several key factors, including a discernible preference for procedures requiring smaller incisions, the incorporation of automated and robotic technologies, a heightened requirement for exactitude and precision in surgical work, alongside enhancements in patient safety benchmarks.

Anticipation surrounds the stereotactic surgery devices sector, projecting considerable expansion across the coming years, with its valuation poised to reach $28.84 billion by 2029, reflecting a consistent compound annual growth rate (CAGR) of 6.5%. This upward trajectory during the projection timeframe is fundamentally driven by several key factors, including the increasing incidence rates of various cancers, the growing incorporation of artificial intelligence and machine learning technologies, the broadening application scope into additional medical fields, an increase in the elderly demographic, and a shift toward more tailored and individualized treatment methodologies. Concurrently, significant developments shaping the market landscape moving forward involve enhanced levels of precision and exactitude, the ongoing trend toward making devices smaller, the increasing adoption of robotic systems and automated processes, the prevalence of patient-specific therapeutic strategies, and the utilization of these devices across a wider array of procedures and clinical uses.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10495&type=smp

Which Industry Drivers Are Expected To Accelerate The Stereotactic Surgery Devices Market From 2025 To 2029?

Anticipated escalation in the incidence of Parkinson’s disease and epilepsy is set to propel the expansion of the stereotactic surgical device sector in the foreseeable future. Parkinson’s disease, characterized by uncontrolled tremors, slowed motion, and muscular rigidity, is a debilitating neurodegenerative condition, while epilepsy involves a disorder of the brain leading to heightened vulnerability to recurrent, spontaneous seizures. These stereotactic surgical instruments currently find application in managing conditions such as movement anomalies, epilepsy, chronic discomfort, psychiatric issues, and Parkinson’s disease itself. To illustrate the scale, a 2022 report from the Parkinson’s Foundation, a national non-profit headquartered in New York, indicated that the United States is projected to see more than 90,000 new Parkinson’s disease diagnoses annually; this represents a fifty percent jump from the prior projection which stood at 60,000 yearly cases. Currently, nearly one million individuals in the US are affected by Parkinson’s disease, and projections suggest this figure will climb to 1.2 million by 2030, underscoring how the growing prevalence of both Parkinson’s disease and epilepsy serves as a catalyst for the stereotactic surgical device market’s advancement.

What Are The Key Segments In The Stereotactic Surgery Devices Market?

The stereotactic surgery devicesmarket covered in this report is segmented –

1) By Product: Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam, CyberKnife

2) By Application: Brain Tumor Treatment, Arteriovenous Malformations Treatment, Parkinsons Disease, Epilepsy, Other Applications

3) By End User: Hospitals, Laboratories

Subsegments:

1) By Gamma Knife: Leksell Gamma Knife Perfexion, Leksell Gamma Knife Icon

2) By Line Accelerator (LINAC) Machines: Conventional LINAC, Image-Guided Radiation Therapy (IGRT) LINAC

3) By Proton Beam: Fixed Beam Proton Therapy Systems, Scanned Beam Proton Therapy Systems

4) By CyberKnife: CyberKnife M6 System, CyberKnife VSI System

What Are The Major Trends Driving The Growth Of The Stereotactic Surgery Devices Market?

A prominent direction shaping the landscape of the stereotactic surgical device arena is the swift progression of technology. Leading firms within this sector are actively innovating to bolster their competitive standing. To illustrate this, in May 2023, the German medical technology firm Brainlab introduced ExacTrac Dynamic Surface, a system designed for surface guided radiation therapy (SGRT) patient tracking and alignment. This platform integrates high velocity thermal surface tracking capability with an enhanced ExacTrac X-ray feedback mechanism, thereby elevating the adaptability and precision employed when placing and supervising patients undergoing diverse procedures such as cranial and spinal stereotactic radiosurgery (SRS) alongside stereotactic body radiation therapy (SBRT). The apparatus functions by projecting a patterned blue light structure onto the patient’s exterior, which is then captured by a pair of three-dimensional imaging devices, with every surface coordinate receiving an additional thermal identification marker that a dedicated, integrated camera proceeds to log.

Who Are The Prominent Global Companies Shaping The Stereotactic Surgery Devices Market?

Major companies operating in the stereotactic surgery devices market include Alliance Oncology, Micromar Industria Commercio Ltda., Adeor Medical AG, Monteris Medical Holding AG, Inomed Medizintechnik GmbH, Ion Beam Applications S.A. (IBA), Elekta AB (publ), Varian Medical Systems Inc., Accuracy Incorporated, Modus Medical Devices Inc., Koninklijke Philips N.V., Huiheng Group Co. Ltd., Mitsubishi Heavy Industries Ltd., GE Healthcare, Siemens AG, Medtronic plc, Brainlab AG, Renishaw plc, Neuropace Inc., Microvention Inc., MR Solutions Ltd., RaySearch Laboratories AB, Alpha Omega Engineering Inc., FHC Inc., Nexstim Plc, Scopis GmbH, IZI Medical Products LLC, Integra LifeSciences Holdings Corporation, Computerized Imaging Reference Systems Inc., MRI Interventions Inc., ZAP Surgical Systems Inc., Schaerer Medical USA Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/stereotactic-surgery-devices-global-market-report

Which Geographies Are Emerging As Strong Markets For The Stereotactic Surgery Devices Industry?

North America was the largest region in the stereotactic surgery devices market in 2024. The regions covered in the stereotactic surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Stereotactic Surgery Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10495&type=smp

Browse Through More Reports Similar to the Global Stereotactic Surgery Devices Market 2025, By The Business Research Company

Cardiovascular Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiovascular Surgery Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Spinal Surgery Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/spinal-surgery-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795